Source: International Congress 2018 – Biomarkers of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lilov (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria). The role of serum IL6 in stable COPD patients. 4066

Member's Comments

No comment yet.

Related content which might interest you: Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 The role of leptin and adiponectin in patients with COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Source: Eur Respir J 2015; 45: 1482-1485 Year: 2015 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013